Exalgo: Oral tablet, extended release (12mg)
Detailed Information
Also see:
- Get answers to Frequently Asked Questions (FAQs)
- Find other class related drugs
- Find additional patient usage statistics
Visit Drug Summary Page
Print
Check Drug InteractionsWhat is this Medicine?
HYDROMORPHONE (hye droe MOR fone) is a pain reliever. It is used to treat moderate to severe pain. It is used by people who have been taking an opioid or narcotic pain medicine.
CVS Pharmacy Patient Statistics for Exalgo: Oral tablet, extended release(12mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Exalgo 12mg Extended-Release Tablet
NDC: 236350412-
Prescription Required
-
Federally Controlled Drug
(CSA Schedule) -
FDA Approved
FDA approved for the following conditions:
Severe Pain, Moderate Pain
Severe Pain, Moderate Pain
Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Exalgo 12mg Extended-Release Tablet
Mallinckrodt Brand Pharmaceuticals Inc
Pill Identification:
EXH 12
Shape: round
Color: yellow
Reported Side Effects for Exalgo 12mg Extended-Release Tablet
Elated Mood
Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Onset: EARLY
Skin Redness
Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Onset: EARLY
Belching
Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Onset: EARLY
Elevated Hepatic Enzymes
Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Onset: DELAYED
Dysphoria
Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Onset: EARLY
Dyskinesia
Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Onset: DELAYED
Dysarthria
Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Onset: DELAYED
Double Vision
Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Onset: EARLY
Confusion
Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Onset: EARLY
Chills
Incidence:
<2.0%*
Severity: MILD
Onset: RAPID
Onset: RAPID
Breathing Difficulties
Incidence:
<2.0%*
Severity: SEVERE
Onset: RAPID
Onset: RAPID
Blurred Vision
Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Onset: EARLY
Mass Trapped In Stomach
Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Onset: DELAYED
Causing To Be Hungry
Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Onset: DELAYED
Anaphylactoid Reactions
Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Onset: RAPID
Thoughts Of Suicide
Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Onset: DELAYED
Convulsions
Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Onset: DELAYED
Inflamed Pancreas
Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Onset: DELAYED
Decreased Memory
Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Onset: DELAYED
Visual Impairment
Incidence:
<2.0%*
Severity: SEVERE
Onset: EARLY
Onset: EARLY
Rapid Heart Rate
Incidence:
<2.0%*
Severity: MODERATE
Onset: RAPID
Onset: RAPID
Restlessness
Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Onset: EARLY
Paresthesias
Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Onset: DELAYED
Paranoia
Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Onset: EARLY
Rapid Heart Rate
Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Onset: EARLY
Rapid Muscle Twitches
Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Onset: DELAYED
Miosis
Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Onset: EARLY
Feeling Sick
Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Onset: EARLY
Decreased Sexual Desire
Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Onset: DELAYED
Increased Urination
Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Onset: EARLY
Impotence (erectile Dysfunction)
Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Onset: DELAYED
Decreased Thinking
Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Onset: EARLY
Hypoesthesia
Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Onset: DELAYED
Overactive Reflexes
Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Onset: DELAYED
Hyperesthesia
Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Onset: DELAYED
High Amylase Levels
Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Onset: DELAYED
Hyperalgesia
Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Onset: DELAYED
Hallucinations
Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Onset: EARLY
Fast Eye Movements
Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Onset: DELAYED
Muscle Pain
Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Onset: EARLY
Low Potassium Levels
Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Onset: DELAYED
High Uric Acid Level
Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Onset: DELAYED
Hemorrhoids
Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Onset: DELAYED
Painful Urination
Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Onset: EARLY
Dehydration
Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Onset: DELAYED
Slow Heart Beat
Incidence:
<2.0%*
Severity: SEVERE
Onset: RAPID
Onset: RAPID
Distressed
Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Onset: EARLY
Low Body Temperature
Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Onset: DELAYED
Ringing In Ears
Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Onset: DELAYED
Shaking
Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Onset: EARLY
Retaining Urine
Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Onset: EARLY
Difficulty Swallowing
Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Onset: DELAYED
Brain Dysfunction
Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Onset: DELAYED
Balance Problems
Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Onset: EARLY
Intestinal Blockage
Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Onset: DELAYED
Dry Eyes
Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Onset: EARLY
Hole In Intestines
Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Onset: DELAYED
Drowsiness
Incidence:
1.0-15.0%*
Severity: MILD
Onset: EARLY
Onset: EARLY
Tired
Incidence:
1.0-11.0%*
Severity: MILD
Onset: EARLY
Onset: EARLY
Excessive Sweating
Incidence:
1.0-6.0%*
Severity: MILD
Onset: DELAYED
Onset: DELAYED
Dry Mouth
Incidence:
1.0-5.0%*
Severity: MILD
Onset: EARLY
Onset: EARLY
Weakness
Incidence:
1.0-11.0%*
Severity: MILD
Onset: DELAYED
Onset: DELAYED
Decreased Appetite
Incidence:
1.0-6.0%*
Severity: MILD
Onset: DELAYED
Onset: DELAYED
Weight Loss
Incidence:
1.0-3.0%*
Severity: MILD
Onset: DELAYED
Onset: DELAYED
Itching
Incidence:
1.0-8.0%*
Severity: MILD
Onset: RAPID
Onset: RAPID
Nervousness
Incidence:
2.0-4.0%*
Severity: MILD
Onset: DELAYED
Onset: DELAYED
Joint Pain
Incidence:
2.0-6.0%*
Severity: MILD
Onset: DELAYED
Onset: DELAYED
Fluid Retention
Incidence:
2.0-5.0%*
Severity: MODERATE
Onset: DELAYED
Onset: DELAYED
Withdrawal
Incidence:
2.0-10.0%*
Severity: MODERATE
Onset: EARLY
Onset: EARLY
Lightheadedness
Incidence:
2.0-11.0%*
Severity: MILD
Onset: EARLY
Onset: EARLY
Chest Pain
Incidence:
2.0%*
Severity: MODERATE
Onset: EARLY
Onset: EARLY
Stomach Pain
Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Onset: EARLY
Fever
Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Onset: EARLY
Skin Rash
Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Onset: EARLY
Depression
Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Onset: DELAYED
Back Pain
Incidence:
3.0-4.0%*
Severity: MILD
Onset: DELAYED
Onset: DELAYED
Loose Stools
Incidence:
3.0-8.0%*
Severity: MILD
Onset: EARLY
Onset: EARLY
Inability To Sleep
Incidence:
3.0-7.0%*
Severity: MILD
Onset: EARLY
Onset: EARLY
Throat Inflammation
Incidence:
4.0%*
Severity: MODERATE
Onset: DELAYED
Onset: DELAYED
Heartburn
Incidence:
4.0%*
Severity: MILD
Onset: DELAYED
Onset: DELAYED
Upset Stomach
Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Onset: EARLY
Headache
Incidence:
5.0-12.0%*
Severity: MILD
Onset: EARLY
Onset: EARLY
Vomiting
Incidence:
6.0-14.0%*
Severity: MILD
Onset: EARLY
Onset: EARLY
Constipation
Incidence:
7.0-31.0%*
Severity: MODERATE
Onset: DELAYED
Onset: DELAYED
Upset Stomach
Incidence:
9.0-28.0%*
Severity: MILD
Onset: EARLY
Onset: EARLY
Addiction
Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
Onset: DELAYED
Addiction
Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Exalgo 12mg Extended-Release Tablet
Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.
Major Lifestyle Interaction
Alcohol and Exalgo 12mg Extended-Release Tablet(Hydromorphone Hydrochloride)
Alcohol and CNS Depressants(Hydromorphone Hydrochloride)
Avoid alcohol-containing drinks while taking this medicine. Using this drug along with alcohol can lead to serious side effects. You may feel drowsy or more tired when taking these drugs together. Do not drive or operate machinery until you know how this drug affects you, and especially if you are drinking alcohol-containing beverages. If you notice slurred speech, confusion, severe weakness, or difficulty breathing, contact your health care provider immediately.
Pregnancy & Lactation Information
FIRST Trimester
Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.
SECOND Trimester
Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.
THIRD Trimester
Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.
Lactation
Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.
Learning More About
Visit the Drug Summary page where you can:
- Get answers to Frequently Asked Questions (FAQs)
- Find other class related drugs
- Find additional patient usage statistics
